positive writeup in afr

The listed biotechnology groups in Australia had mixed fortunes in 2005. Somedid not do well, as investors got sick of pouring money into companies with nonew products and no profits. There are few global "blockbuster" drugscoming from the sector. Some critics believe that many biotechnology groupslisted too soon and will deliver little to investors. The success stories in2005 include Pharmaxis, ChemGenex, Mesoblast, Ventracor, CSL, Biota and Biodiem.The smart money in 2005 went into mining groups, as the resources sector boomed.Some biotechnology groups failed to deliver on their promises. However, it isnot all gloom and doom for 2006. Biotechnology stocks likely to do well in 2006include Pharmaxis, Alchemia and Acrux